Core Life Analytics Closes €1m Series A Deal

The Netherlands-based data analytics company, Core Life Analytics, an UMCU spin-off, has closed a €1m Series A financing round. The investor team is composed of BOM Brabant Ventures, Utrecht Holdings and TechFund One.

Below you will find the issued press release of Core Life Analytics:

Utrecht, The Netherlands, May 28th, 2020 – Core Life Analytics markets the StratoMineR data analytics platform in the life sciences sector. StratoMineR enables biologists to analyze complex biological datasets without the need for internal data analysis support. The software is being successfully used by scientists at well established companies such as Pfizer, Janssen, and Galapagos. CEO David Egan stated, “This investment in Core Life Analytics will allow us to expand our sales & marketing efforts, and to accelerate product development. We believe that we now have an excellent team that will be able to support us, not just with funding, but also with advice and extensive business networks.” CTO Wienand Omta stated, “This investment allows Core Life Analytics to expand our development team and accelerate the software development process by working on multiple modules simultaneously.”

Core Life Analytics will be moving its headquarters from Utrecht to Den Bosch in Noord-Brabant. Sjoerd van Gorp of BOM stated, “We are very impressed with the achievements of the management team and believe that Core Life Analytics adds strong data analytics expertise to our life sciences ecosystem. By enabling biologists to unlock hidden information in increasingly complex biological datasets, new innovative drugs can be developed with an improved understanding of the underlying mechanism of action. This increases the chances of success in drug development.”

“We are excited at the prospect of opening an office in Den Bosch,” said CTO Wienand Omta. “Working in close proximity to The Jheronimus Academy of Data Science will present many opportunities for collaboration on software and data science projects.”

Oscar Schoots, the CEO of Utrecht Holdings, was impressed with Core Life Analytics’ ability to turn a tool developed at the University Medical Center Utrecht into a viable product with a growing customer base. He is happy that Utrecht Holdings could invest together with Tech Fund One and BOM to help to grow the business. He stated, “We are very glad to see that with this Series A deal Core Life Analytics is making the next step in bringing a world class data analytics solution, that originated in the UMCU, to the global market.”

“Core Life Analytics fits perfectly in our fund and we are glad to provide them, together with the BOM and Utrecht Holdings, the required funding.” said Peter van Meersbergen of TechFund One. “Their innovative business model and data analytics technology gives new opportunities to life science and pharmaceutical companies to do better and faster analysis of their research data. The current global search for vaccines and therapies for Covid-19 underline how sound this proposition is.”

Core Life Analytics
Core Life Analytics was co-founded by CEO David Egan and CTO Wienand Omta in 2016 to commercialize the StratoMineR data analytics platform. StratoMineR was originally developed by the co-founders at the Cell Screening Core at the UMC Utrecht’s Department of Cell Biology in collaboration with the University of Utrecht’s Department of Information and Computing Sciences. The software allows biologists in pharmaceutical companies, biotechnology companies and academia to independently analyze complex data sets.

StratoMineR is being successfully used by scientists at pharmaceutical companies, biotechnology companies and academic centers of excellence. It helps to accelerate preclinical drug discovery projects at all stages, including target discovery, lead molecule identification, lead characterization and toxicology. It has recently been used to identify novel inhibitors of SARS-CoV-2 infection. For more information, visit

About BOM Brabant Ventures
With the help of its unique knowledge and capital, BOM uses the Brabant Ventures label to focus on the accelerated and future-proof growth of ambitious Brabant startups and scaleups in the High-Tech Systems and Software, Agri-food, Life Sciences & Health, Maintenance, Supply Chain, and Bio-based Economy top industries. For more information, visit

About Utrecht Holdings
Utrecht Holdings consists of UMC Utrecht Holding BV and Universiteit Utrecht Holding BV, both subsidiaries of respectively the University Medical Center Utrecht and Utrecht University (The Netherlands). Utrecht Holdings invests in promising spin-offs and intellectual property originating from scientific research at both institutions. For more information, visit

About TechFund One Investment fund
Techfund One, an initiative of De Breed & Partners ( ) and Investormatch. TechFund One invests in market driven potentially successful Dutch tech companies, with a scalable new product, process, or service recently introduced to the market, and realizing first turnover. For more information, visit

David A. Egan Ph.D.
Core Life Analytics BV
Tel: +31 64 217 0956